Health News Archive - February 03, 2010
CLEVELAND, Feb. 3 /PRNewswire/ -- Ganeden Biotech Inc., maker of the patented probiotic strain GanedenBC30Â®, today announced a partnership with Pathway International Pty Ltd. to exclusively distribute GanedenBC30 in all Australian and New Zealand markets.
SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that Odysseas D. Kostas, M.D. will join its Board of Directors. Dr. Kostas also will serve on the Board's Audit Committee. Dr.
LAWRENCE, Mass., Feb. 3 /PRNewswire-FirstCall/ -- NxStage Medical, Inc.
WALTHAM, Mass., Feb.
TOKYO and EDISON, N.J., Feb. 3 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568), announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor.
SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- OrexigenÂ® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the 12th Annual BIO CEO and Investor Conference.
LIVONIA, Mich., Feb. 3 /PRNewswire/ -- To commemorate Low Vision Awareness Month this February, Dr.
Scientists at the University of California, Berkeley, have created smart nanoprobes that may one day be used in the battle against cancer to selectively seek out and destroy tumor cells, as well as report back on the mission's status.
FREEHOLD, N.J., Feb. 3 /PRNewswire-FirstCall/ -- Speedus Corp. (Nasdaq: SPDE), announced today that it has engaged Morgan Joseph & Co.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.